EurekAlert!

C-Path launches consortium to support medical product development in sickle cell disease

TUCSON, Ariz., Sept. 17, 2020 -- The Critical Path Institute (C-Path) today announced the launch of the Critical Path for Sickle Cell Disease (CP-SCD) Consortium to support collaboration and ...
EurekAlert!

C-Path’s pioneering neuroscience workshop transforms the landscape of neurological disorder therapies

Critical Path Institute (C-Path) is pleased to announce the release of a new peer-reviewed publication, titled “Transforming Drug Development for Neurological Disorders: Proceedings from a ...
Business Wire

CDISC, C-Path Release Therapeutic Area Standard to Drive Research Forward for Clostridium Difficile Associated Diarrhea

AUSTIN, Texas & TUCSON, Ariz.--(BUSINESS WIRE)--CDISC and The Critical Path Institute (C-Path) are pleased to announce the release of a global Therapeutic Area Standard, which describes how to use ...
Arizona Daily Star

Tucson-based Critical Path Institute emerging as top drug-research organization

The Tucson-based Critical Path Institute has no laboratories, no drug chemists, no patent lawyers. Yet the nonprofit is arguably one of the most important emerging drug-research organizations in the ...
Business Wire

Critical Path Institute Announces New CEO

TUCSON, Ariz.--(BUSINESS WIRE)--Critical Path Institute (C-Path) announced today that Dr. Carolyn Compton has joined the organization as its new president and chief executive officer. Dr. Compton ...
Arizona Daily Star

C-Path gets $9 million in funding

The Tucson-based Critical Path Institute has been awarded a $9 million investment grant from Science Foundation Arizona to boost the institute's mission of improving the drug development process.
RAPS

C-Path Obtains EMA, FDA Approval for Tool to Expedite Development of Alzheimer's Treatments

The Critical Path Institute (C-Path), a public-private hybrid organization supported directly by the US Food and Drug Administration (FDA), has announced a "big step forward for Alzheimer's disease ...
News Medical

C-Path awarded FDA grant to establish Rare Disease Clinical Outcome Assessment Consortium

The U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) has funded a cooperative agreement to establish a Rare Disease Clinical Outcome Assessment (COA) Consortium ...
News Medical

C-Path and FARA announce launch of Friedreich's Ataxia Integrated Clinical Database

Critical Path Institute's (C-Path) Data Collaboration Center (DCC) and the Friedreich's Ataxia Research Alliance (FARA) today announced the launch of the Friedreich's Ataxia Integrated Clinical ...
MarketWatch

C-Path Announces Gender Equitable Medicines for Parkinson's Disease (GEM-PD) Initiative

C-Path expands its worldwide leadership in accelerating drug development in neurology; seeks additional collaborators to broaden impact. TUCSON, Ariz., Nov. 13, 2024 /PRNewswire/ -- Critical Path ...
PR Newswire

C-Path Europe: A Global Vision of Success

"We are pleased with the progress and continued development of our global efforts in the regulatory and data science spaces," said C-Path Europe's Managing Director Cécile Ollivier, M.S. "As our work ...